Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.81 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.76 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.76 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.70 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.70 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.70 |
| ▸ | LDHA | P00338 | 1/20 | 0.70 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.70 |
| ▸ | FBP1 | P09467 | 1/20 | 0.70 |
| ▸ | SRC | P12931 | 1/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.70 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.70 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.70 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.70 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.70 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20341113 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL7882477 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL18785113 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL11927745 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL4546151 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL48174 | 1.00 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| Water SCHEMBL112387 | 0.99 | POLB (0.79) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| Triphosphate SCHEMBL27892354 | 0.96 | POLB (0.81) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL24538794 | 0.93 | POLB (0.77) | POLBENPP1P2RY1DNPH1PRKAB2 | |
| SCHEMBL8742200 | 0.93 | POLB (0.77) | POLBENPP1P2RY1DNPH1PRKAB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118109537-A | Application of halogenating enzyme in catalytic synthesis of 2' -halogenated nucleoside monophosphate | 香港中文大学（深圳） | 2024-05-31 | — | — | CN | claimed |
| US-20220401617-A1 | ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS | REVBIO INC (US) | 2022-12-22 | — | — | US | claimed |
| EP-4054548-A1 | ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS | RevBio, Inc. (US) | 2022-09-14 | — | — | EP | claimed |
| US-8110676-B2 | Prodrugs activated by RNA-dependent DNA-polymerases | PROTERA S.R.L. (IT) | 2012-02-07 | — | — | US | claimed |
| US-20050136673-A1 | CMP slurry | XU WEN-QING (US) | 2005-06-23 | — | — | US | claimed |
| WO-2005014746-A1 | CMP SLURRY | NYACOL NANO TECHNOLOGIES, INC. (US) | 2005-02-17 | — | — | WO | claimed |
| US-20050028450-A1 | CMP slurry | XU WEN-QING (US) | 2005-02-10 | — | — | US | claimed |
| US-20250049488-A1 | DEVICES AND METHODS FOR BONE FIXATION | REVBIO INC (US) | 2025-02-13 | — | — | US | disclosed |
| US-20240368682-A1 | SYSTEMS AND METHODS FOR CLONAL REPLICATION AND AMPLIFICATION OF NUCLEIC ACID MOLECULES FOR GENOMIC AND THERAPEUTIC APPLICATIONS | REDVAULT BIOSCIENCES LP (US) | 2024-11-07 | — | — | US | disclosed |
| EP-4447833-A2 | DEVICES AND METHODS FOR BONE FIXATION | RevBio, Inc. (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240180625-A1 | IMAGE GUIDED DELIVERY OF COMPOSITIONS AND RELATED METHODS | REVBIO INC (US) | 2024-06-06 | — | — | US | disclosed |
| CN-118109537-A | Application of halogenating enzyme in catalytic synthesis of 2' -halogenated nucleoside monophosphate | 香港中文大学（深圳） | 2024-05-31 | — | — | CN | disclosed |
| US-20230329755-A1 | BONE FLAP FIXATION DEVICE | REVBIO INC (US) | 2023-10-19 | — | — | US | disclosed |
| EP-0604409-A4 | COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION. | ISIS PHARMACEUTICALS INC (US) | 1996-06-12 | — | — | EP | disclosed |
| WO-1995007364-A1 | NUCLEIC ACID LIGANDS AND IMPROVED METHODS FOR PRODUCING THE SAME | NEXSTAR PHARMACEUTICALS, INC. (US) | 1995-03-16 | — | — | WO | disclosed |
| EP-0604409-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0519053-A4 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | — | 1993-03-31 | — | — | EP | disclosed |
| EP-0519053-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES. | PROMEGA CORP (US) | 1992-12-23 | — | — | EP | disclosed |
| WO-1992012261-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | PROMEGA CORPORATION (US) | 1992-07-23 | — | — | WO | disclosed |
| WO-1991010671-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1991-07-25 | — | — | WO | disclosed |